Michelle Mellion
Corporate Officer/Principal bij PEPGEN INC.
Vermogen: - $ op 30-04-2024
Profiel
Michelle L.
Mellion is a professional with experience in the pharmaceutical industry.
She is currently the Senior Vice President-Clinical Development at PepGen Inc. Prior to this, she worked as an Executive Medical Director at Fulcrum Therapeutics, Inc. from 2018 to 2022.
She also worked as a Medical Director at Vertex Pharmaceuticals, Inc. from 2016 to 2018 and as an Associate Medical Director at Biogen, Inc. from 2015 to 2016.
Dr. Mellion holds a doctorate degree from Wake Forest University and an undergraduate degree from Colgate University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PEPGEN INC.
-.--% | 31-03-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Michelle Mellion
| Bedrijven | Functie | Begin |
|---|---|---|
| PEPGEN INC. | Corporate Officer/Principal | 01-04-2022 |
Eerdere bekende functies van Michelle Mellion
| Bedrijven | Functie | Einde |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Corporate Officer/Principal | 01-03-2022 |
| VERTEX PHARMACEUTICALS INCORPORATED | Hoofd Techniek/Wetenschap/O&O | 01-08-2018 |
| BIOGEN INC. | Corporate Officer/Principal | 01-11-2016 |
Opleiding van Michelle Mellion
| Wake Forest University | Doctorate Degree |
| Colgate University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| PEPGEN INC. | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| BIOGEN INC. | Health Technology |